EP. 3: Treatment of Metastatic HER2-Positive Breast Cancer
May 26th 2021
Dr Kaklamani and colleagues highlight key clinical trials such as DESTINY-Breast01, HER2CLIMB, NALA, and SOPHIA in the setting of advanced HER2-positive breast cancer and discuss the practical considerations of these data.